Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Presentations
Prospectus
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
IslandWatch Newsletter
Contact
Contact Us
Subscribe for Email Alerts
Investor Centre
Investor Centre
>
Research Coverage
Investor Welcome
Clinical programme
ASX Announcements
Presentations
Prospectus
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Research Coverage
5-Dec-2024
Pitt Street Research: Initial Phase II results look good
15-Oct-2024
Pitt Street Research: A company-defining 12 months lie ahead
8-Apr-2024
MST Access: Data to confirm PEACH trial
6-Feb-2024
MST Access: SAD Trial Cohort 3
20-Nov-2023
MST Access: Clinical program starts
12-Oct-2023
MST Access: Clinical program to start
11-Jan-2023
MST Access: IND submission starts the clock
22-Dec-2022
MST Access: Phase 2a trial on track for early CY23
25-Nov-2022
MST Access: Trial to start early CY23
27-Jul-2022
MST Access initiates research coverage on Island Pharmaceuticals
Click here for archives
.png){kind=logo}
